NovelStem International Corp.: Form 10-K for the period ended Dec 31, 2023
Filed with the SEC on Apr 1, 2024 and accepted by EDGAR at Apr 1, 2024, 15:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Operating income | 12 months2023-01-01 to 2023-12-31 | −$3.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-01-01 to 2023-12-31 | $99.0k | us-gaap:InterestExpense |
| Net income | 12 months2023-01-01 to 2023-12-31 | −$4.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2023-01-01 to 2023-12-31 | −$0.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-01-01 to 2023-12-31 | −$0.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-01-01 to 2023-12-31 | 46,881,475 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-01-01 to 2023-12-31 | −$348.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Current assets | At period end2023-12-31 | $86.6k | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $2.3m | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $346.5k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $4.2m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-12-31 | −$2.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001493152-24-012323. Last ingested by Listed: Oct 24, 2026, 15:00 ET. Listed shows no prices and gives no investment advice.